Does NAD⁺ cause cancer? A video description weighing mouse, human and drug evidence
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description says the creator, a scientist with 25 years in cancer biology, addresses the weekly question of whether NAD⁺ causes cancer, citing mouse studies, human trial data and a breast cancer drug built on NAD⁺ biology, and offers a fuel-versus-spark framework for reading such headlines. [1]
The description says the creator spent 25 years studying cancer biology, including 16 years in genomics and precision oncology, and gets the NAD⁺-and-cancer question weekly, often from women who just finished breast cancer treatment. [1]
The description says the video offers a fuel-versus-spark framework for reading "X feeds cancer" headlines, without defining the terms there. [1]
The description states the video is science education, not medical advice, and that NAD⁺ and its precursors are not FDA-approved to prevent or treat cancer. [1]
Creator's stated cancer-biology background
The description presents the creator as someone who spent 25 years studying cancer biology, including 16 years in genomics and precision oncology, and who also discusses NAD⁺ often. She says she gets the question about NAD⁺ and cancer every week, often from women who just finished breast cancer treatment, and that she answers it for Breast Cancer Awareness Month. The description frames the video as the honest version covering the study that started the panic, mouse studies, human trial data and a breast cancer drug built on NAD⁺ biology. [1]
Fuel-versus-spark framework for headlines
The description says the video offers one framework to help viewers read every "X feeds cancer" headline from now on: fuel versus spark. It does not explain in the description how fuel and spark are defined or applied. The description also lists references, including a bioluminescent probe study on nicotinamide riboside uptake and metastasis, a study on de novo NAD⁺ synthesis and liver tumours, a mouse study on a NAD⁺ precursor and hepatocellular cancer, and work on NAMPT inhibitors in oncology. [1]
Stated limits: education, not medical advice
The description states that the video is science education, not medical advice, and that NAD⁺ and its precursors are not FDA-approved to prevent or treat cancer. It advises consulting a qualified healthcare provider before starting any new protocol and, for people who have or had cancer, making these decisions with the oncology team. The creator describes herself as a scientist, educator and coach, not a medical provider, and notes that individual results vary. The description also discloses a brand partnership with a telehealth platform and a commission link. [1]
Context & limits
Only the video description was reviewed; the video and transcript were not reviewed. The description names studies and a framework but does not report their designs, samples, results or uncertainties, so no findings can be confirmed from it.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
I get this question every single week
fuel vs spark
not FDA-approved to prevent or treat cancer
About this video
Creator description · original textText language: English
Dr. Kristi Sawicki · 34 min · Source published: 2026-10-07
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.